FDA's Deborah Autor to join drugmaker Mylan

Tue Apr 30, 2013 3:55pm EDT

(Reuters) – Generic drugmaker Mylan Inc said on Tuesday it has hired Deborah Autor, deputy commissioner for global regulatory operations and policy at the U.S. Food and Drug Administration, to help oversee its global regulatory strategy.

John M. Taylor, III, Counselor to the Commissioner, will take Autor’s place in an acting capacity as the agency looks for a replacement, FDA Commissioner Margaret Hamburg said in an email to staff.

Visit the Source Site

FDA’s Deborah Autor to join drugmaker Mylan

Tue Apr 30, 2013 3:55pm EDT

(Reuters) – Generic drugmaker Mylan Inc said on Tuesday it has hired Deborah Autor, deputy commissioner for global regulatory operations and policy at the U.S. Food and Drug Administration, to help oversee its global regulatory strategy.

John M. Taylor, III, Counselor to the Commissioner, will take Autor’s place in an acting capacity as the agency looks for a replacement, FDA Commissioner Margaret Hamburg said in an email to staff.


Visit the Source Site

Antibiotic-resistant ground turkey found in 21 states: report

By Carey Gillam

KANSAS CITY | Tue Apr 30, 2013 4:20pm EDT

KANSAS CITY (Reuters) – Dangerous antibiotic-resistant bacteria has been found in ground turkey on U.S. grocery shelves across a variety of brands and stores located in 21 states, according to a report by a consumer watchdog organization.

Of the 257 samples of ground turkey tested, more than half were found to be positive for fecal bacteria and overall, 90 percent were contaminated with one or more types of disease-causing organisms, many of which proved resistant to one or more common antibiotics, Consumer Reports found.

How much do financial interests sway researchers?

By Genevra Pittman

NEW YORK | Tue Apr 30, 2013 3:40pm EDT

NEW YORK (Reuters Health) – Funding from drug companies and other potential conflicts of interest did not influence the conclusions reached by researchers testing new cancer treatments over the past few years, according to a new analysis.

But Dr. Aaron Kesselheim, who has looked into that issue at the Harvard School of Public Health, pointed out that other studies have shown the opposite.

Shingles jab for people in their 70s

29 April 2013 Last updated at 20:31 ET

By Michelle Roberts Health editor, BBC News online

Shingles rashThe rash can be extremely painful and blister

People in their 70s in England, Scotland and Northern Ireland will be offered a vaccine against shingles from this September.

Experts have been recommending routine immunisation for some years.

The government-led programme will target 70, 78 and 79-year-olds in the first instance and should prevent tens of thousands of shingles cases a year.

Elderly people are at greatest risk and vaccination should prevent nearly half of cases in the over 70s.

Europe's regulator digs in for drug data fight

By Ben Hirschler

LONDON | Tue Apr 30, 2013 8:36am EDT

LONDON (Reuters) – Europe’s medicines regulator has been stopped from releasing clinical trial data about drugs made by AbbVie and Intermune, following a court ruling favoring the two U.S. companies.

The European Medicines Agency said on Tuesday it intended to appeal the interim decision by the European Union’s general court.

The court action, which prevents the European Medicines Agency (EMA) from releasing documents until a final ruling is given, highlights the battle between campaigners for more transparency and companies who fear it will harm their business.

Europe’s regulator digs in for drug data fight

By Ben Hirschler

LONDON | Tue Apr 30, 2013 8:36am EDT

LONDON (Reuters) – Europe’s medicines regulator has been stopped from releasing clinical trial data about drugs made by AbbVie and Intermune, following a court ruling favoring the two U.S. companies.

The European Medicines Agency said on Tuesday it intended to appeal the interim decision by the European Union’s general court.

The court action, which prevents the European Medicines Agency (EMA) from releasing documents until a final ruling is given, highlights the battle between campaigners for more transparency and companies who fear it will harm their business.

Do school programs keep kids from smoking?

By Andrew M. Seaman

NEW YORK | Tue Apr 30, 2013 2:43pm EDT

NEW YORK (Reuters Health) – Certain school-based programs that aim to keep kids from smoking cigarettes seem to work, according to a fresh look at some past research.

After examining over a hundred “gold standard” studies, researchers found that school-based programs that teach children life skills and self esteem were linked to a significant reduction in the number who started using tobacco down the road.

ECG Alarm Alerts Docs to Silent Killer

Register Today

Earn Free CME Credits by reading the latest medical news
in your specialty.

Sign Up

38763

By Chris Kaiser, Cardiology Editor, MedPage Today

Published: April 30, 2013

Reviewed by F. Perry Wilson, MD, MSCE; Instructor of Medicine, Perelman School of Medicine at the University of Pennsylvania

Action Points

  • Note that this single-center study demonstrated that prolonged QT intervals on ECGs were associated with all-cause mortality in hospitalized patients.
  • Be aware that only patients who had been ordered an ECG as part of clinical care could be included, potentially biasing the results.